BACKGROUND: The aim of this study was to see the efficacy of endorectal coil MRI and MR spectroscopic imaging in patients with elevated serum PSA and negative transrectal ultrasonography (TRUS)-guided biopsy.
MATERIALS AND METHODS: This study was conducted on 87 patients presented with: - Elevated prostatic specific antigen levels >5 ng/ml. - Symptoms and signs of prostatic carcinoma. - Patients with negative TRUS-guided biopsy. - Suspicious lesion on TRU. All the patients were subjected to TRUS and followed by TRUS-guided biopsy of the lesion identified on endorectal coil MRI and MR-Spectroscopy. TRUS-guided biopsy of prostate was done with a Siemens Sonoline Adana Scanner. The scanning was performed by mechanical probe 5-7.5 MHz.
RESULTS: Out of 87 patients, 43 (49.4%) had hypointense lesion, 11 (12.6%) had hyperintense lesion. Out of 87 patients, MR-spectroscopy showed peak choline-creatine in 74 patients. Normal citrate peak was seen in 13 patients. Patients who had choline-creatine peak, among them 28 (37.8%) had peak in left peripheral zone, 23 (31.1%) had peak in the right peripheral zone, 2 (2.7%) had peak in the central zone, 17 had (23%) peak bilaterally. Four patients (5.4%) had peaks in right and central zones. The difference was statistically significant (P < 0.001).
CONCLUSION: Prostatic biopsy directed with endorectal coil MRI and MR-spectroscopic imaging findings in patients with elevated serum PSA and prior negative biopsy, improves the early diagnosis of prostatic carcinoma and accurate localization of prostate cancer within the gland.
Written by:
Ganie FA, Wani MS, Shaheen F, Wani ML, Ganie SA, Mir MF, Wani SN, Masaratul-Gani. Are you the author?
Department of CVTS, SKIMS, Srinagar, Jammu and Kashmir, India.
Reference: Urol Ann. 2013 Jul;5(3):172-8.
doi: 10.4103/0974-7796.115741
PubMed Abstract
PMID: 24049380
UroToday.com Prostate Cancer Section
